Found: 24
Select item for more details and to access through your institution.
The immune response in cancer: from immunology to pathology to immunotherapy.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2015, v. 467, n. 2, p. 127, doi. 10.1007/s00428-015-1787-7
- By:
- Publication type:
- Article
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7649, doi. 10.3390/ijms23147649
- By:
- Publication type:
- Article
Comment faire progresser les connaissances sur la toxicité des immunothérapies en 2024 ?
- Published in:
- Revue Immunité & Cancer, 2023, v. 7, n. 4, p. 159
- By:
- Publication type:
- Article
Actualités de l’ESMO 2022 en onco-urologie : l’immunothérapie toujours sur le devant de la scène… avec des résultats variables.
- Published in:
- Revue Immunité & Cancer, 2022, v. 6, n. 4, p. 187
- By:
- Publication type:
- Article
ASCO GU 2021: nouvelles associations et nouvelles cibles.
- Published in:
- Revue Immunité & Cancer, 2021, v. 5, n. 2, p. 93
- By:
- Publication type:
- Article
Tim-3: Biomarqueur et cible thérapeutique en cancérologie.
- Published in:
- Médecine Sciences, 2018, v. 34, n. 3, p. 231, doi. 10.1051/medsci/20183403011
- By:
- Publication type:
- Article
Biomarkers from the tumor microenvironment to predict clinical response to checkpoint inhibitors.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 4, p. 117, doi. 10.13032/tjop.2052-5931.100111.
- By:
- Publication type:
- Article
Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
- Published in:
- European Heart Journal, 2018, v. 39, n. 38, p. 3553, doi. 10.1093/eurheartj/ehy485
- By:
- Publication type:
- Article
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 5, p. 1377, doi. 10.1007/s00345-020-03528-x
- By:
- Publication type:
- Article
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 6, p. 981, doi. 10.1007/s00262-017-2058-z
- By:
- Publication type:
- Article
Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6167, doi. 10.3390/cancers14246167
- By:
- Publication type:
- Article
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5548, doi. 10.3390/cancers13215548
- By:
- Publication type:
- Article
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 678, doi. 10.3390/cancers13040678
- By:
- Publication type:
- Article
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC).
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 231, doi. 10.3390/cancers13020231
- By:
- Publication type:
- Article
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1673, doi. 10.3390/cancers12061673
- By:
- Publication type:
- Article
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/3449660
- By:
- Publication type:
- Article
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2341165, doi. 10.1001/jamanetworkopen.2023.41165
- By:
- Publication type:
- Article
Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1335, doi. 10.1002/ijc.34126
- By:
- Publication type:
- Article
The clinical role of the TME in solid cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity.
- Published in:
- Brain Communications, 2023, v. 5, n. 3, p. 1, doi. 10.1093/braincomms/fcad169
- By:
- Publication type:
- Article
Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2018, v. 121, n. 2, p. 203, doi. 10.1111/bju.13855
- By:
- Publication type:
- Article
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma ( RCC) treated with sunitinib.
- Published in:
- BJU International, 2014, v. 114, n. 1, p. 81, doi. 10.1111/bju.12494
- By:
- Publication type:
- Article
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 433, doi. 10.1093/oncolo/oyac262
- By:
- Publication type:
- Article
Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195042
- By:
- Publication type:
- Article